BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma

GSK Acquires Efimosfermin from Boston Pharmaceuticals in $2 Billion Deal to Advance Liver Disease Pipeline

Affecting up to 5% of the global population, SLD represents an area of significant unmet medical need with limited treatment options Phase II data show ...

May 15, 2025 | News

BD Launches FACSDiscover™ A8 Cell Analyzer to Expand Access to Advanced Spectral and Real-Time Imaging Technologies

New BD FACSDiscover™ A8 Cell Analyzer Brings Leading-Edge Capabilities to Wider Range of Scientists across Academia and Biopharma BD (Becton...

May 14, 2025 | News

Roche and Genentech Invest $700M in First U.S. East Coast Facility to Advance Obesity Drug Manufacturing

Future 700,000 sq. ft. facility in Holly Springs, NC, will support pharma division’s metabolic medicines portfolio $700+ million investm...

May 13, 2025 | News

AstraZeneca’s BREZTRI AEROSPHERE Demonstrates Significant Lung Function Gains in Phase III Asthma Trials

Positive high-level results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that AstraZeneca’s fixed-dose tripl...

May 05, 2025 | News

Merck to Acquire SpringWorks Therapeutics for $3.9 Billion, Strengthening Rare Tumor Leadership

Purchase price of $47 per share in cash represents an enterprise value of €3.0 billion ($3.4 billion), or an equity value of approximately $3.9 bill...

April 28, 2025 | News

Thermo Fisher to Invest $2 Billion in U.S. Manufacturing and Innovation Expansion

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will invest an additional $2 billion in the United States over the next fou...

April 25, 2025 | News

GC Cell Secures Exclusive Rights to DAAN Biotherapeutics’ Tumor Antigen-Specific Antibody for CAR-T and CAR-NK Therapies

DAAN Biotherapeutics, a leading innovative drug development company specializing in T-Cell receptor (TCR)-based therapies, has signed an exclusi...

April 22, 2025 | News

How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market

In this exclusive email interaction with BioPharma APAC, Alessandra Ambruosi, Director & Head of Solid Formulations & Pharm Materia...

April 02, 2025 | Interview

ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma

As the demand for plant-based and clean-label pharmaceutical solutions grows, ACG Capsules has positioned itself at the forefront of innovation with its ve...

March 06, 2025 | Interview

Daiichi Sankyo and AstraZeneca’s ENHERTU Recommended for EU Approval for HER2 Low and HER2 Ultralow Metastatic Breast Cancer

Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq: AZN) ENHERTU® (trastuzumab deruxtecan) has been recommended for approval in th...

March 03, 2025 | News

Pfizer and Astellas Announce Sustained Survival Benefit in Advanced Urothelial Cancer with PADCEV® and KEYTRUDA® Combination

Enfortumab vedotin plus pembrolizumab continues to demonstrate superior efficacy versus chemotherapy in a broad population, reinforcing the combination a...

February 11, 2025 | News